Carol Ashe

Insider Reports History

Entity
Individual
Location
C/O Aptose Biosciences Inc., 251 Consumers Road, Suite 1105, Toronto, Ontario, Canada
Signature
/s/ Carol Ashe
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Carol Ashe:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Elicio Therapeutics, Inc. Director Stock Option (right to buy) 4.1K Dec 28, 2023 Direct
Aptose Biosciences Inc. Director Director Stock Option (Right to Buy) 3.33K Feb 5, 2024 Direct

Insider Reports Filed by Carol Ashe

Symbol Company Period Transactions Value $ Form Type Date Filed Role
APTO Aptose Biosciences Inc. Feb 5, 2024 1 $0 4 Feb 7, 2024 Director
ELTX Elicio Therapeutics, Inc. Dec 28, 2023 1 $0 4 Dec 29, 2023 Director
ELTX Elicio Therapeutics, Inc. Jun 1, 2023 0 $0 3 Jun 7, 2023 Director
APTO Aptose Biosciences Inc. Jan 19, 2023 1 $0 4 Jan 23, 2023 Director
APTO Aptose Biosciences Inc. Jan 18, 2022 1 $0 4 Jan 20, 2022 Director